Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

著者: Pascal Vranckx, Marco Valgimigli, Lars Eckardt, Jan G.P. Tijssen, Thorsten Lewalter, Giuseppe Gargiulo, Valerii Batushkin, Gianluca Campo, Zoreslava Lysak, Vakaliuk Ip, Krzysztof Milewski, Petra Laeis, Paul‐Egbert Reimitz, Rüdiger Smolnik, Wolfgang Zierhut, Andreas Goette - The Lancet 2019 被引用: 659